Moderna The stock price once fell 10%, with the cumulative decline over days reaching 26%
according to BIT market data,Moderna the stock price once fell 10%, with the cumulative decline over days reaching 26%. Previously, its jointly developed personalized melanoma vaccine with Merck had its Phase data leaked prematurely. Reports indicated positive clinical results, but the market still saw a sell-off.